Clinical trial NCT01497548 - References

Depression — Study of Methylphenidate as Add on Therapy in Depressed Cancer Patients

Citation(s)

•   Bennett B, Goldstein D, Lloyd A, Davenport T, Hickie I
  Fatigue and psychological distress--exploring the relationship in women treated for breast cancer. Eur J Cancer. 2004 Jul;40(11):1689-95.
•   Candy M, Jones L, Williams R, Tookman A, King M
  Psychostimulants for depression. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006722. doi: 10.1002/14651858.CD006722.pub2. Review.
•   Challman TD, Lipsky JJ
  Methylphenidate: its pharmacology and uses. Mayo Clin Proc. 2000 Jul;75(7):711-21. Review.
•   Chochinov HM
  Depression in cancer patients. Lancet Oncol. 2001 Aug;2(8):499-505. Review.
•   Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CL Jr
  The prevalence of psychiatric disorders among cancer patients. JAMA. 1983 Feb 11;249(6):751-7.
•   Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, Gralow J
  Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry. 2008 Mar-Apr;30(2):112-26. doi: 10.1016/j.genhosppsych.2007.10.008. Review.
•   Green CR, Montague L, Hart-Johnson TA
  Consistent and breakthrough pain in diverse advanced cancer patients: a longitudinal examination. J Pain Symptom Manage. 2009 May;37(5):831-47. doi: 10.1016/j.jpainsymman.2008.05.011. Epub 2008 Dec 2.
•   Kadan-Lottick NS, Vanderwerker LC, Block SD, Zhang B, Prigerson HG
  Psychiatric disorders and mental health service use in patients with advanced cancer: a report from the coping with cancer study. Cancer. 2005 Dec 15;104(12):2872-81.
•   Knobf MT
  Psychosocial responses in breast cancer survivors. Semin Oncol Nurs. 2007 Feb;23(1):71-83. Review.
•   Laval G, Paris A
  [Methylphenidate in palliative care in cancer patient: a double-blind randomised trial versus placebo]. Bull Cancer. 2008 Feb;95(2):241-6. doi: 10.1684/bdc.2008.0581. French.
•   Marek Kaminski, Per Sjogren
  The Use of psychostimulants in palliative and supportive treatment of cancer patients. Advances in Palliative Medicine 2007; 6: 23-31.
•   Masand PS, Tesar GE
  Use of stimulants in the medically ill. Psychiatr Clin North Am. 1996 Sep;19(3):515-47. Review.
•   Massie, M
  J., Popkin, M.K. Depressive Disorders. In: Holland, J.C. (Eds), Psycho-oncology. Oxford University Press, NY 1998; 518-519.
•   McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB
  Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry. 1995 Feb;52(2):89-99. Review.
•   Pasquini M, Biondi M
  Depression in cancer patients: a critical review. Clin Pract Epidemiol Ment Health. 2007 Feb 8;3:2.
•   Raison CL, Miller AH
  Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry. 2003 Aug 1;54(3):283-94. Review.
•   Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RK; Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based Care
  The treatment of depression in cancer patients: a systematic review. Support Care Cancer. 2007 Feb;15(2):123-36. Epub 2006 Oct 21. Review.
•   Rozans M, Dreisbach A, Lertora JJ, Kahn MJ
  Palliative uses of methylphenidate in patients with cancer: a review. J Clin Oncol. 2002 Jan 1;20(1):335-9. Review.
•   Somerset W, Stout SC, Miller AH, Musselman D
  Breast cancer and depression. Oncology (Williston Park). 2004 Jul;18(8):1021-34; discussion 1035-6, 1047-8. Review.
•   Vigano A, Watanabe S, Bruera E
  Methylphenidate for the management of somatization in terminal cancer patients. J Pain Symptom Manage. 1995 Feb;10(2):167-70.

A Parallel-group, Double-blind, Placebo-controlled Study of Methylphenidate as an Add on Therapy for Mirtazapine in the Treatment of Major Depressive Disorder in Cancer Patients Under Palliative Care

Details for clinical trial NCT01497548